Evaluation of the impact of the proteasome inhibitor on calcium channel expression in cardiomyocytes treated with doxorubicin Cover

.blurhash-client-img { display: none !important; }

Evaluation of the impact of the proteasome inhibitor on calcium channel expression in cardiomyocytes treated with doxorubicin

Current Issues in Pharmacy and Medical Sciences

Volume 31 (2018): Issue 1 (March 2018)

By: Agnieszka Korga, Milena Soroka, Karolina Wicha, Ewelina Humeniuk, Grzegorz Adamczuk, Magdalena Iwan, Marcin Sysa and Jaroslaw Dudka

Open Access

|Apr 2018

Authors

Agnieszka Korga

agnieszka.korga@umlub.pl

Independent Medical Biology Unit, Medical University of Lublin, Poland

Milena Soroka

Independent Medical Biology Unit, Medical University of Lublin, Poland

Karolina Wicha

Independent Medical Biology Unit, Medical University of Lublin, Poland

Ewelina Humeniuk

Chair and Department of Toxicology, Medical University of Lublin, Poland

Grzegorz Adamczuk

Chair and Department of Toxicology, Medical University of Lublin, Poland

Magdalena Iwan

Independent Medical Biology Unit, Medical University of Lublin, Poland

Marcin Sysa

Chair and Department of Toxicology, Medical University of Lublin, Poland

Jaroslaw Dudka

Chair and Department of Toxicology, Medical University of Lublin, Poland

DOI: https://doi.org/10.1515/cipms-2018-0004 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X

Journal RSS Feed

Language: English

Page range: 18 - 21

Submitted on: Sep 25, 2017

|

Accepted on: Nov 13, 2017

|

Published on: Apr 11, 2018

Published by: Sciendo

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

cardiotoxicity,

calcium channels

Related subjects:

Clinical medicine,

Clinical medicine, other,

Pharmacology, toxicology,

Pharmacy, other

© 2018 Agnieszka Korga, Milena Soroka, Karolina Wicha, Ewelina Humeniuk, Grzegorz Adamczuk, Magdalena Iwan, Marcin Sysa, Jaroslaw Dudka, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 31 (2018): Issue 1 (March 2018)Next article